SCHEDULE: Vanguard Group Discloses 5.63% Stake in Microbot Medical Inc.

The Vanguard Group has reported a beneficial ownership of 5.63% in Microbot Medical Inc.'s common stock as of June 30, 2025.

Summary

• The Vanguard Group, an investment adviser based in Malvern, PA, has filed a Schedule 13G indicating beneficial ownership in Microbot Medical Inc.
• As of June 30, 2025, Vanguard beneficially owns an aggregate of 2,050,638 shares of Microbot Medical Inc. common stock.
• This ownership represents 5.63% of the total class of securities.
• Vanguard holds sole dispositive power over 2,030,667 shares and shared dispositive power over 19,971 shares.
• Vanguard reports no sole or shared voting power over these shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: The filing is a factual disclosure of beneficial ownership by a major institutional investor. While not directly positive or negative about the company's operations, the presence of a large, passive institutional holder like Vanguard is generally viewed as a neutral to slightly positive signal for market confidence and liquidity.

Positives

• The disclosure of a significant stake by a major institutional investor like The Vanguard Group can signal confidence in Microbot Medical Inc.'s long-term prospects.
• Vanguard's acquisition of shares is stated to be in the ordinary course of business, indicating a passive investment strategy rather than an activist one.

Negatives

• NA

Risks

• NA

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding Microbot Medical Inc.'s future performance or strategic direction.

Industry Context

This Schedule 13G filing indicates that a major passive institutional investor, The Vanguard Group, has taken a significant stake in Microbot Medical Inc. Such filings are routine disclosures required when an entity acquires more than 5% of a company's voting shares. For the medical device and robotics industry, increased institutional ownership can sometimes be viewed as a positive indicator of market interest and potential stability, though this filing itself does not provide operational or strategic insights.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake may increase investor confidence and potentially improve liquidity for Microbot Medical Inc.'s stock.

Key Dates

Keywords

Microbot Medical Inc., Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Medical Devices, Robotics, Healthcare